Interplay between pathogenic Th17 and regulatory T cells
- 1 November 2007
- journal article
- review article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 66 (Supplement), iii87-iii90
- https://doi.org/10.1136/ard.2007.078527
Abstract
Autoimmune diseases arise from a break in tolerance toward self-antigens and are characterised by the development of pathogenic T cell populations infiltrating the target organ. Regulatory T cells play an important role in maintaining self-tolerance through their inhibitory functions on effector T cells. The usage of ex vivo-generated regulatory T cells (Treg) has been regarded as a potentially attractive therapeutic approach for autoimmune diseases. However, the dynamics of Treg in autoimmunity are not well understood. Here, we summarise our published findings on the interplay between Treg and Th17 effector cells in vivo during experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis. We have developed Foxp3gfp "knock-in" mice and myelin oligodendrocyte glycoprotein (MOG)(35-55)/IA(b) (MHC class II)-tetramers to track autoantigen-specific Treg in vivo during EAE. On immunisation with MOG, Treg cells were detected in the central nervous system (CNS) as early as day 10. However, at the onset of disease, the accumulation of MOG-specific effector T cells (T-eff) largely prevailed. Subsequently, during remission T-eff rapidly contracted whereas a highly suppressive Treg population persisted in the CNS. The interplay between effector Th17 and Treg extend beyond their functions in vivo as we and others have identified the factors responsible for Th17 differentiation. While TGF-beta is a critical differentiation factor for Treg cells, IL6 completely inhibits the generation of Treg cells induced by TGF-beta. Instead, IL6 and TGF-beta together induce the differentiation of pathogenic Th17 cells. Our data demonstrate a dichotomy in the generation of Th17 cells that induce autoimmunity and Treg cells that inhibit autoimmune tissue injury.Keywords
This publication has 29 references indexed in Scilit:
- Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammationNature Medicine, 2007
- Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα TherapyThe Journal of Experimental Medicine, 2004
- Suppressor T Cells in Human DiseasesThe Journal of Experimental Medicine, 2004
- CD25+ CD4+ T Cells, Expanded with Dendritic Cells Presenting a Single Autoantigenic Peptide, Suppress Autoimmune DiabetesThe Journal of Experimental Medicine, 2004
- Foxp3 and Natural Regulatory T CellsImmunity, 2003
- Visualizing the course of antigen‐specific CD8 and CD4 T cell responses to a growing tumorEuropean Journal of Immunology, 2003
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- IL-12p35-Deficient Mice Are Susceptible to Experimental Autoimmune Encephalomyelitis: Evidence for Redundancy in the IL-12 System in the Induction of Central Nervous System Autoimmune DemyelinationThe Journal of Immunology, 2002
- Interferon‐γ confers resistance to experimental allergic encephalomyelitisEuropean Journal of Immunology, 1996
- Animal modelsAnnals of Neurology, 1994